As the BA.2 variant circulates, will you need a second COVID-19 booster?
As the BA.2 variant of the coronavirus gains traction around the world, you may be wondering whether you’ll need a second COVID-19 booster shot.
While...
This new COVID-19 vaccine could prevent future infectious diseases
A new study from Northwestern University found just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in...
Aspirin may improve survival for people with severe COVID-19
A new study from Imperial College London found antiplatelet drugs such as aspirin have little effect on the need for life support in COVID-19,...
This new oral drug may prevent death from COVID-19
The immune system deteriorates with age, making COVID-19 particularly deadly in older people—but to date, no clinically available medication addresses this key risk factor.
A...
Scientists find a universal antibody therapy for all COVID-19 variants
In a new study from the University of Alabama at Birmingham, researchers discovered a monoclonal antibody that potentially acts as a potent universal coronavirus...
This new PCR test can detect all COVID-19 variants
In a new study from Rutgers University and elsewhere, researchers developed a PCR test that uses molecular beacons not only to diagnose COVID-19 infection,...
COVID-19 Delta breakthrough infection can strongly benefit these people
A new study from King's College London found a delta breakthrough infection generates a potent and broad neutralizing antibody response in double vaccinated individuals.
The...
Cognitive problems linked to higher death risk in COVID-19 pandemic
In a new study, researchers found that higher death rates are linked to the COVID-19 pandemic among older adults with cognitive impairment, like Alzheimer's...
‘Long COVID’ may lead to lingering airways disease, study finds
A new study from the University of Iowa found disease of the small airways in the lungs is a potential long-lasting effect of COVID-19.
They...
This drug may prevent severe COVID-19, new study finds
In a new study from the William Osler Health Centre, researchers found for people with mild-to-moderate COVID-19 and a high risk for progression, sotrovimab...